Effective treatment of oral lichen planus with the JAK inhibitor baricitinib

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

Authors

Anthony Moussa¹, Themis Colla¹, Brendan Morrison², Rodney Sinclair^{1

3}

Affiliations

¹ Sinclair Dermatology, East Melbourne, Victoria, Australia.
² Australian Clinical Labs, Traralgon, Victoria, Australia.
³ University of Melbourne, Melbourne, Victoria, Australia.

PMID: 35213737
DOI: 10.1111/ajd.13811

No abstract available

Publication types

Letter

MeSH terms

Azetidines* / therapeutic use
Humans
Janus Kinase Inhibitors* / therapeutic use
Lichen Planus, Oral* / drug therapy
Purines / therapeutic use
Pyrazoles
Sulfonamides

Substances

Azetidines
Janus Kinase Inhibitors
Purines
Pyrazoles
Sulfonamides
baricitinib